Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice

Infection and Immunity

Volumn 68, Issue 3, 2000, Pages 1231-1234

  Cooper, Andrea M ^a   Segal, Brahm H ^b   Frank, Anthony A ^a   Holland, Steven M ^b   Orme, Ian M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; GRANULOMA; INFECTION RESISTANCE; KNOCKOUT MOUSE; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; GRANULOMA; INTERFERON TYPE II; MICE; MICE, KNOCKOUT; NADPH OXIDASE; PHOSPHOPROTEINS; REACTIVE OXYGEN SPECIES; TUBERCULOSIS, PULMONARY;

EID: 0033975318     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.3.1231-1234.2000     Document Type: Article

References (27)

1. Adams, L. B., M. C. Dinauer, D. E. Morgenstern, and J. L. Krahenbuhl. 1997. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuherc. Lung Dis. 78:237-246.
2. Allen, D. M., and H. H. Chng. 1993. Disseminated Mycobacterium flavescens in a probable case of chronic granulomatous disease. J. Infect. 26:83-86.
3. Chan, J., X. Fan, S. W. Hunter, P. J. Brennan, and B. R. Bloom. 1991. Lipoarabinomannan, a possible virulence factor involved in the persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59:1755-1761.
4. Chan, J., K. Tanaka, D. Carroll, J. L. Flynn, and B. R. Bloom. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-740.
5. Chan, J., Y. Xing, R. Magliozzo, and B. R. Bloom. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
6. Chusid, M. J., J. E. Parillo, and A. S. Fauci. 1975. Chronic granulomatous disease. Diagnosis in a 27-year-old man with Mycobacterium fortuitum. JAMA 233:1295-1296.
7. Clark, R. A., and S. J. Klebanoff. 1979. Chemotactic factor inactivation by the myeloperoxidase-hydrogen peroxide-halide system. J. Clin. Investig. 64: 913-920.
8. Cooper, A. M., J. E. Callahan, J. P. Griffin, A. R. Roberts, and I. M. Orme. 1995. Old mice are able to control low-dose aerogenic infections with Mycobacterium tuberculosis. Infect. Immun. 63:3259-3265.
9. Esterly, J. R., W. Q. Sturner, N. B. Esterly, and D. B. Windhorst. 1971. Disseminated BCG in twin boys with presumed chronic granulomatous disease of childhood. Pediatrics 48:141-144.
10. Finkel, T. 1999. Signal transduction by reactive oxygen species in non-phagocytic cells. J. Leukoc. Biol. 65:337-340.
11. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
12. Gallin, J. I., E. S. Buescher, B. E. Seligmann, J. Nath, T. Gaither, and P. Katz. 1983. NIH conference. Recent advances in chronic granulomatous disease. Ann. Intern. Med. 99:657-674.
13. Hamasaki, T., T. Sakano, M. Kobayashi, N. Sakura, K. Ueda, and T. Usui. 1989. Leukotriene B4 metabolism in neutrophils of patients with chronic granulomatous disease: phorbol myristate acetate decreases endogenous leukotriene B4 via NADPH oxidase-dependent mechanism. Eur. J. Clin. Investig. 19:404-411.
14. Henderson, W. R., and S. J. Klebanoff. 1983. Leukotriene production and inactivation by normal, chronic granulomatous disease and myeloperoxidase deficient neutrophils. J. Biol. Chem. 258:13522-13527.
15. Jackett, P. S., V. R. Aber, and D. B. Lowrie. 1978. Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. J. Gen. Microbiol. 104:37-45.
16. phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182:751-758.
17. MacMicking, J. D., R. J. North, R. LaCourse, J. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of NOS2 as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-5248.
18. Middlebrook, G. 1954. Isoniazid-resistance and catalase activity of tubercle bacilli. Am. Rev. Tuberc. 69:471-472.
19. Morgenstern, D. E., M. A. Gifford, L. L. Li, C. M. Doerschuk, and M. C. Dinauer. 1997. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J. Exp. Med. 185:207-218.
20. Nathan, C. F. 1986. Interferon gamma and macrophage activation in cell mediated immunity, p. 165-184. In R. M. Steinman and R. J. North (ed.), Mechanisms of host resistance to infectious agents, tumours and allografts. The Rockefeller Universitv Press, New York, N.Y.
21. Ohga, S., K. Ikeuchi, R. Kadoya, K. Okada, C. Miyazaki, S. Suita, and K. Ueda. 1997. Intrapulmonary Mycobacterium avium infection as the first manifestation of chronic granulomatous disease. J. Infect. 34:147-150.
22. Pedrosa, J., B. M. Saunders, R. Appelberg, I. M. Orme, M. T. Silva, and A. M. Cooper. 2000. Neutrophils play a protective, nonphagocytic, role in systemic Mycobacterium tuberculosis infection of mice. Infect. Immun. 68: 577-583.
23. Pollock, J. D., D. A. Williams, M. A. C. Gifford, L. L. Lui, X. Du, J. Fisherman, S. H. Orkni, C. M. Doerschuk, and M. C. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202-209.
24. Rhoades, E. R., and I. M. Orme. 1997. Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates. Infect. Immun. 65:1189-1195.
25. Schaible, U. E., S. Sturgill-Koszycki, P. H. Schlesinger, and D. G. Russell. 1998. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160:1290-1296.
26. phox-/- mouse model of chronic granulomatous disease has normal granuloma formation and cytokine responses to Mycobacterium avium and Schistosoma mansoni eggs. Infect. Immun. 67:1659-1665.
27. Smith, P. A., and D. F. Wittenberg. 1984. Disseminated BCG infection in a child with chronic granulomatous disease. A case report. S. Afr. Med. J. 65:821-822.